In 2012, I had my first psychedelic experiences, as a subject in a clinical trial at Johns Hopkins University School of Medicine’s Behavioral Pharmacology Research Unit. I was given two doses of psilocybin spaced a month apart to treat my cancer-related depression.
During one session, deep within the world the drug evoked, I found myself inside a steel industrial space. Women were bent over long tables,
READ MORE
